您当前的位置:
首页 >
文章列表页 >
Chinese Medicines Regulate p38 MAPK, ERK1/2, and JNK in Treatment of Osteoporosis: A Review
更新时间:2023-05-16
    • Chinese Medicines Regulate p38 MAPK, ERK1/2, and JNK in Treatment of Osteoporosis: A Review

      增强出版
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 29, Issue 12, Pages: 222-229(2023)
    • DOI:10.13422/j.cnki.syfjx.20230343    

      CLC: R2-0;R22;R33;G353.11;R681
    • Received:21 November 2022

      Published Online:02 March 2023

      Published:20 June 2023

    移动端阅览

  • QI Yanzhe,WANG Zi,OUYANG Hougan,et al.Chinese Medicines Regulate p38 MAPK, ERK1/2, and JNK in Treatment of Osteoporosis: A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(12):222-229. DOI: 10.13422/j.cnki.syfjx.20230343.

  •  
  •  

0

Views

31

下载量

10

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Role of p38 MAPK Pathway in Diabetic Peripheral Neuropathy and Chinese Medicine Intervention: A Review
Mechanism of Chinese Medicine in Promoting Angiogenesis After Ischemic Stroke Based on PI3K/Akt Signaling Pathway: A Review
Anti-osteoporosis Effect of Isorhamnetin: A Review
Traditional Chinese Medicine Intervention in Depression Based on Signaling Pathway Regulation: A Review
Chinese Medicine Regulates Ferroptosis to Treat Lung Cancer: A Review

Related Author

YANG Peng
ZHANG Chengfei
ZHANG Yaqi
PENG Chuan
ZHANG Qiue
WU Lili
QIN Lingling
LIU Tonghua

Related Institution

The First Clinical School of Medicine, Shaanxi University of Chinese Medicine
Key Laboratory of Traditional Chinese Medicine (TCM) and Health Sciences, Ministry of Education, Beijing University of Chinese Medicine
Dongzhimen Hospital, Beijing University of Chinese Medicine
Chengdu University of TCM
The First Affiliated Hospital of Henan University of Chinese Medicine
0